{
  "version": "1.0.0",
  "medications": [
    {
      "id": "asa",
      "name": "Aspirin",
      "class": "Antiplatelet",
      "inpatient": {
        "load": "162–325 mg PO chewed once",
        "maint": "81 mg PO daily"
      },
      "avoid": ["Active bleeding", "Severe aspirin allergy"],
      "pearls": [
        "Prefer chewable for loading; consider PPI with DAPT if GI risk."
      ]
    },
    {
      "id": "p2y12",
      "name": "P2Y12 inhibitor (ticagrelor/clopidogrel/prasugrel)",
      "class": "Antiplatelet",
      "inpatient": {
        "load": "Per strategy (e.g., ticagrelor 180 mg PO once)",
        "maint": "Per agent (e.g., ticagrelor 90 mg BID)"
      },
      "avoid": ["Active bleeding", "History of ICH (prasugrel)"],
      "pearls": ["Choose agent per PCI/lysis strategy and bleeding risk."]
    },
    {
      "id": "heparin",
      "name": "Heparin (UFH) / Fondaparinux",
      "class": "Anticoagulant",
      "inpatient": {
        "load": "UFH bolus per protocol",
        "maint": "UFH infusion titrated by anti‑Xa/aPTT"
      },
      "avoid": ["Active bleeding", "Hx HIT (avoid heparin)"],
      "pearls": ["Select per renal function/strategy; monitor closely."]
    },
    {
      "id": "statin_high",
      "name": "High‑intensity statin",
      "class": "Lipid lowering",
      "outpatient": {
        "maint": "Atorvastatin 40–80 mg or Rosuvastatin 20–40 mg daily"
      },
      "pearls": [
        "Check lipids; counsel on myalgias; consider drug interactions."
      ]
    },
    {
      "id": "beta_blocker",
      "name": "Evidence‑based β‑blocker",
      "class": "Beta‑blocker",
      "outpatient": {
        "maint": "Carvedilol, metoprolol succinate, or bisoprolol; titrate to HR/BP"
      },
      "avoid": ["Acute decompensated HF with shock/pulmonary edema"],
      "pearls": ["Initiate after stabilization in ACS/HF."]
    },
    {
      "id": "nitrates",
      "name": "Nitrates (SL nitroglycerin)",
      "class": "Vasodilator",
      "inpatient": { "prn": "0.4 mg SL q5min up to 3 doses for chest pain" },
      "avoid": ["RV infarct", "Recent PDE‑5 inhibitor use", "Hypotension"],
      "pearls": ["Prefer SL early; topical/IV per BP and relief."]
    },
    {
      "id": "o2_prn",
      "name": "Oxygen if hypoxic",
      "class": "Supportive",
      "pearls": ["Use only if hypoxic; target SpO2 per protocol."]
    },
    {
      "id": "arni_or_ace_arb",
      "name": "ARNI or ACEi/ARB",
      "class": "RAAS",
      "outpatient": {
        "maint": "Sacubitril/valsartan preferred; otherwise ACEi/ARB per BP/renal function"
      },
      "avoid": [
        "Hx angioedema (ACEi/ARNI)",
        "Pregnancy",
        "Severe hyperkalemia"
      ],
      "pearls": ["Washout 36 h when switching ACEi → ARNI."]
    },
    {
      "id": "mra",
      "name": "Mineralocorticoid receptor antagonist",
      "class": "MRA",
      "outpatient": { "maint": "Spironolactone 12.5–25 mg daily; titrate" },
      "avoid": ["K+ >5.0", "Severe renal dysfunction"],
      "pearls": ["Monitor BMP/K+ within 1–2 weeks after changes."]
    },
    {
      "id": "sglt2i",
      "name": "SGLT2 inhibitor",
      "class": "SGLT2i",
      "outpatient": { "maint": "Dapagliflozin or empagliflozin 10 mg daily" },
      "avoid": ["History of DKA", "Severe renal failure per label"],
      "pearls": [
        "Hold during severe illness/procedures; counsel on GU effects."
      ]
    },
    {
      "id": "loop_diuretic",
      "name": "Loop diuretic",
      "class": "Diuretic",
      "inpatient": { "init": "IV furosemide ≈ 1–2× home PO dose" },
      "outpatient": { "prn": "Titrate to weight/symptoms" },
      "pearls": ["Consider thiazide add‑on for diuretic resistance."]
    },
    {
      "id": "ace_arb_arn",
      "name": "ACEi/ARB/ARNI (per BP/tolerance)",
      "class": "RAAS",
      "outpatient": { "maint": "Select agent per comorbidity and BP" }
    },
    {
      "id": "ace_arb",
      "name": "ACE inhibitor or ARB",
      "class": "RAAS inhibitor",
      "outpatient": {
        "maint": "Lisinopril 10-40 mg daily or Losartan 50-100 mg daily"
      },
      "avoid": ["Pregnancy", "Hyperkalemia", "Angioedema history"],
      "pearls": [
        "First-line for HTN; check K+ and creatinine after initiation."
      ]
    },
    {
      "id": "thiazide",
      "name": "Thiazide/thiazide-like diuretic",
      "class": "Diuretic",
      "outpatient": {
        "maint": "Hydrochlorothiazide 25-50 mg daily or Chlorthalidone 25 mg daily"
      },
      "avoid": ["Severe hyponatremia", "Gout exacerbation"],
      "pearls": ["Preferred diuretic for HTN; monitor electrolytes."]
    },
    {
      "id": "ccb",
      "name": "Calcium channel blocker",
      "class": "Calcium channel blocker",
      "outpatient": {
        "maint": "Amlodipine 5-10 mg daily or Nifedipine XL 30-60 mg daily"
      },
      "avoid": ["Severe aortic stenosis", "Cardiogenic shock"],
      "pearls": ["Effective for HTN; watch for peripheral edema."]
    },
    {
      "id": "warfarin",
      "name": "Warfarin",
      "class": "Vitamin K antagonist",
      "inpatient": { "maint": "Dose to INR 2.0-3.0" },
      "outpatient": { "maint": "Dose to INR 2.0-3.0 with regular monitoring" },
      "avoid": ["Active bleeding", "Pregnancy"],
      "pearls": ["Requires frequent INR monitoring; many drug interactions."]
    },
    {
      "id": "doac",
      "name": "Direct oral anticoagulant (DOAC)",
      "class": "Direct anticoagulant",
      "outpatient": {
        "maint": "Apixaban 5 mg BID, Rivaroxaban 20 mg daily, or Dabigatran 150 mg BID"
      },
      "avoid": ["Active bleeding", "Severe renal impairment (varies by agent)"],
      "pearls": [
        "Preferred over warfarin for most patients; dose adjust for renal function."
      ]
    },
    {
      "id": "diltiazem",
      "name": "Diltiazem",
      "class": "Non-dihydropyridine CCB",
      "inpatient": {
        "maint": "Immediate-release 30-90 mg QID or extended-release per formulation"
      },
      "outpatient": { "maint": "Extended-release 120-360 mg daily" },
      "avoid": ["Severe LV dysfunction", "Heart block"],
      "pearls": ["Effective for rate control in atrial fibrillation."]
    },
    {
      "id": "metoprolol",
      "name": "Metoprolol",
      "class": "Beta-blocker",
      "inpatient": { "maint": "Immediate-release 25-100 mg BID" },
      "outpatient": { "maint": "Metoprolol succinate 50-200 mg daily" },
      "avoid": ["Severe bradycardia", "Decompensated heart failure"],
      "pearls": [
        "Rate control for atrial fibrillation; use succinate form for HF."
      ]
    },
    {
      "id": "digoxin",
      "name": "Digoxin",
      "class": "Cardiac glycoside",
      "inpatient": {
        "maint": "0.125-0.25 mg daily (adjust for age/renal function)"
      },
      "outpatient": { "maint": "0.125-0.25 mg daily with level monitoring" },
      "avoid": ["Hyperkalemia", "Severe renal impairment"],
      "pearls": ["Monitor digoxin levels; narrow therapeutic window."]
    },
    {
      "id": "nsaid",
      "name": "NSAID (ibuprofen)",
      "class": "Anti-inflammatory",
      "inpatient": { "maint": "400-600 mg PO q8h" },
      "avoid": [
        "Active GI bleed",
        "Severe renal impairment",
        "CHF exacerbation"
      ],
      "pearls": ["Use with PPI for GI protection; monitor renal function."]
    },
    {
      "id": "colchicine",
      "name": "Colchicine",
      "class": "Anti-inflammatory",
      "inpatient": {
        "load": "1.2 mg PO once",
        "maint": "0.6 mg PO q12h x 3-6 doses"
      },
      "avoid": ["Severe renal/hepatic impairment"],
      "pearls": ["For pericarditis; monitor for GI toxicity."]
    },
    {
      "id": "steroid",
      "name": "Prednisone",
      "class": "Corticosteroid",
      "inpatient": { "maint": "20-40 mg PO daily taper" },
      "avoid": ["Active infection", "Uncontrolled diabetes"],
      "pearls": ["Use for refractory pericarditis; taper slowly."]
    },
    {
      "id": "fluid_resuscitation",
      "name": "IV Fluid Resuscitation",
      "class": "Supportive",
      "inpatient": { "init": "500-1000 mL NS bolus" },
      "avoid": ["Fluid overload", "Severe HF"],
      "pearls": ["For tamponade stabilization; monitor hemodynamics."]
    },
    {
      "id": "ace_inhibitors",
      "name": "ACE Inhibitors",
      "class": "ACE Inhibitor",
      "medications": [
        "Benazepril (Lotensin)",
        "Captopril (Capoten)",
        "Enalapril (Vasotec)",
        "Fosinopril (Monopril)",
        "Lisinopril (Zestril/Prinivil)",
        "Moexipril (Univasc)",
        "Perindopril (Aceon)",
        "Quinapril (Accupril)",
        "Ramipril (Altace)",
        "Trandolapril (Mavik)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": [
        "Pregnancy",
        "Hyperkalemia",
        "Angioedema history",
        "Bilateral renal artery stenosis"
      ],
      "pearls": [
        "First-line for HTN and HF; monitor K+ and creatinine; cough common side effect."
      ]
    },
    {
      "id": "ace_diuretic_combos",
      "name": "ACE Inhibitor/Diuretic Combinations",
      "class": "ACE Inhibitor + Diuretic",
      "medications": [
        "Accuretic (Quinapril/HCTZ)",
        "Capozide (Captopril/HCTZ)",
        "Lotensin HCT (Benazepril/HCTZ)",
        "Monopril HCT (Fosinopril/HCTZ)",
        "Prinzide (Lisinopril/HCTZ)",
        "Uniretic (Moexipril/HCTZ)",
        "Vaseretic (Enalapril/HCTZ)",
        "Zestoretic (Lisinopril/HCTZ)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Convenient combination for HTN; monitor electrolytes closely."
      ]
    },
    {
      "id": "arbs",
      "name": "Angiotensin II Receptor Blockers (ARBs)",
      "class": "ARB",
      "medications": [
        "Azilsartan Medoxomil (Edarbi)",
        "Candesartan (Atacand)",
        "Eprosartan (Teveten)",
        "Irbesartan (Avapro)",
        "Losartan (Cozaar)",
        "Olmesartan (Benicar)",
        "Telmisartan (Micardis)",
        "Valsartan (Diovan)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Bilateral renal artery stenosis"],
      "pearls": [
        "Alternative to ACEi if cough; monitor K+ and creatinine; less cough than ACEi."
      ]
    },
    {
      "id": "arb_diuretic_combos",
      "name": "ARB/Diuretic Combinations",
      "class": "ARB + Diuretic",
      "medications": [
        "Atacand HCT (Candesartan/HCTZ)",
        "Avalide (Irbesartan/HCTZ)",
        "Benicar HCT (Olmesartan/HCTZ)",
        "Diovan HCT (Valsartan/HCTZ)",
        "Edarbyclor (Azilsartan/Chlorthalidone)",
        "Hyzaar (Losartan/HCTZ)",
        "Micardis HCT (Telmisartan/HCTZ)",
        "Teveten HCT (Eprosartan/HCTZ)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Convenient combination for HTN; monitor electrolytes and renal function."
      ]
    },
    {
      "id": "beta_blockers",
      "name": "Beta Blockers",
      "class": "Beta-Blocker",
      "medications": [
        "Acebutolol (Sectral)",
        "Atenolol (Tenormin)",
        "Betaxolol (Kerlone)",
        "Bisoprolol (Zebeta)",
        "Carvedilol (Coreg, Coreg CR)",
        "Labetalol (Trandate)",
        "Metoprolol (Lopressor, Toprol-XL)",
        "Metoprolol tartrate (immediate release)",
        "Metoprolol succinate (extended release)",
        "Nadolol (Corgard)",
        "Nebivolol (Bystolic)",
        "Pindolol (Visken)",
        "Propranolol (Inderal, InnoPran XL)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to HR/BP goal" },
      "avoid": [
        "Severe bradycardia",
        "Decompensated HF",
        "Asthma/COPD (non-selective agents)"
      ],
      "pearls": [
        "Rate control for AF/atrial flutter; evidence-based for HF/ACS; fatigue common."
      ]
    },
    {
      "id": "beta_blocker_diuretic_combos",
      "name": "Beta Blocker/Diuretic Combinations",
      "class": "Beta-Blocker + Diuretic",
      "medications": [
        "Corzide (Nadolol/Bendroflumethiazide)",
        "Inderide (Propranolol/HCTZ)",
        "Lopressor HCT (Metoprolol/HCTZ)",
        "Tenoretic (Atenolol/Chlorthalidone)",
        "Ziac (Bisoprolol/HCTZ)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to HR/BP goal" },
      "avoid": [
        "Severe bradycardia",
        "Decompensated HF",
        "Severe renal impairment"
      ],
      "pearls": [
        "Convenient combination; monitor electrolytes and renal function."
      ]
    },
    {
      "id": "ccb_non_dhp",
      "name": "Non-Dihydropyridine Calcium Channel Blockers",
      "class": "Non-DHP CCB",
      "medications": [
        "Diltiazem (Cardizem, Cardizem LA, Cardizem CD, Cartia XT, Dilacor XR, Diltzac, Diltia XT, Taztia XT, Tiazac)",
        "Verapamil (Isoptin SR, Calan, Covera-HS, Verelan)"
      ],
      "outpatient": {
        "maint": "Diltiazem 120-360 mg daily; Verapamil 120-480 mg daily"
      },
      "avoid": ["Severe LV dysfunction", "Heart block", "WPW with AF"],
      "pearls": [
        "Effective for rate control in AF; negative inotrope; constipation with verapamil."
      ]
    },
    {
      "id": "ccb_dhp",
      "name": "Dihydropyridine Calcium Channel Blockers",
      "class": "DHP CCB",
      "medications": [
        "Amlodipine (Norvasc)",
        "Felodipine (Plendil)",
        "Isradipine (DynaCirc, DynaCirc CR)",
        "Nicardipine (Cardene, Cardene SR)",
        "Nifedipine (Adalat, Procardia, Procardia XL, Adalat CC)",
        "Nisoldipine (Sular)"
      ],
      "outpatient": {
        "maint": "Amlodipine 5-10 mg daily; others per formulation"
      },
      "avoid": ["Severe aortic stenosis", "Cardiogenic shock"],
      "pearls": [
        "Effective for HTN; peripheral edema common; amlodipine preferred for HF."
      ]
    },
    {
      "id": "direct_renin_inhibitors",
      "name": "Direct Renin Inhibitors",
      "class": "Direct Renin Inhibitor",
      "medications": ["Aliskiren (Tekturna)", "Tekturna HCT (Aliskiren/HCTZ)"],
      "outpatient": { "maint": "Aliskiren 150-300 mg daily" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Less commonly used; monitor K+ and creatinine; avoid with ACEi/ARB."
      ]
    },
    {
      "id": "hf_medications",
      "name": "Heart Failure Medications",
      "class": "Heart Failure",
      "medications": [
        "BiDil (Hydralazine/Isosorbide Dinitrate)",
        "Corlanor (Ivabradine)",
        "Entresto (Sacubitril/Valsartan)"
      ],
      "outpatient": { "maint": "Per agent dosing; titrate to symptoms" },
      "avoid": ["Severe hypotension", "Bradycardia (ivabradine)"],
      "pearls": [
        "BiDil for African Americans with HF; ivabradine for HFrEF with HR >70; Entresto preferred over ACEi."
      ]
    },
    {
      "id": "aldosterone_antagonists",
      "name": "Aldosterone Antagonists",
      "class": "MRA",
      "medications": [
        "Eplerenone (Inspra)",
        "Spironolactone (Aldactone)",
        "Aldactazide (Spironolactone/HCTZ)"
      ],
      "outpatient": {
        "maint": "Spironolactone 12.5-50 mg daily; Eplerenone 25-50 mg daily"
      },
      "avoid": ["K+ >5.0", "Severe renal dysfunction", "Pregnancy"],
      "pearls": [
        "Monitor K+ closely; gynecomastia with spironolactone; evidence-based for HFrEF."
      ]
    },
    {
      "id": "antiadrenergic_agents",
      "name": "Antiadrenergic Agents",
      "class": "Antiadrenergic",
      "medications": [
        "Clonidine (Catapres, Catapres-TTS, Patch)",
        "Doxazosin (Cardura, Cardura XL)",
        "Guanabenz (Wytensin)",
        "Guanfacine (Tenex)",
        "Methyldopa (Aldomet)",
        "Prazosin (Minipress)",
        "Terazosin (Hytrin)",
        "Aldoril (Methyldopa/HCTZ)",
        "Minizide (Prazosin/Polythiazide)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": [
        "Severe bradycardia",
        "Pheochromocytoma (unopposed alpha-blockade)"
      ],
      "pearls": [
        "Second-line for HTN; clonidine for rebound HTN; methyldopa for pregnancy HTN."
      ]
    },
    {
      "id": "diuretics",
      "name": "Diuretics",
      "class": "Diuretic",
      "medications": {
        "Carbonic Anhydrase Inhibitors": [
          "Acetazolamide (Diamox, Diamox Sequels)"
        ],
        "Loop Diuretics": [
          "Bumetanide (Bumex)",
          "Furosemide (Lasix)",
          "Torsemide (Demadex)"
        ]
      },
      "outpatient": {
        "maint": "Titrate to symptoms/weight; monitor electrolytes"
      },
      "avoid": ["Severe electrolyte abnormalities", "Anuria"],
      "pearls": [
        "Loop diuretics first-line for HF; monitor renal function and electrolytes."
      ]
    },
    {
      "id": "thiazide_diuretics",
      "name": "Thiazide Diuretics",
      "class": "Thiazide Diuretic",
      "medications": [
        "Chlorothiazide (Diuril)",
        "Chlorthalidone (Thalitone)",
        "Hydrochlorothiazide (HCTZ, Microzide)",
        "Indapamide (Lozol)",
        "Metolazone (Zaroxolyn)"
      ],
      "outpatient": { "maint": "12.5-50 mg daily; titrate to BP goal" },
      "avoid": [
        "Severe hyponatremia",
        "Gout exacerbation",
        "Severe renal impairment"
      ],
      "pearls": [
        "First-line for HTN; monitor electrolytes; chlorthalidone may be more effective."
      ]
    },
    {
      "id": "ace_ccb_combos",
      "name": "ACE Inhibitor/CCB Combinations",
      "class": "ACE Inhibitor + CCB",
      "medications": [
        "Lexxel (Enalapril/Felodipine)",
        "Lotrel (Benazepril/Amlodipine)",
        "Tarka (Trandolapril/Verapamil)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Convenient dual mechanism for HTN; monitor K+ and creatinine."
      ]
    },
    {
      "id": "ccb_direct_renin_combos",
      "name": "CCB/Direct Renin Inhibitor Combinations",
      "class": "CCB + Direct Renin Inhibitor",
      "medications": ["Tekamlo (Amlodipine/Aliskiren)"],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Triple mechanism for resistant HTN; monitor K+ and creatinine."
      ]
    },
    {
      "id": "ccb_direct_renin_diuretic_combos",
      "name": "CCB/Direct Renin Inhibitor/Diuretic Combinations",
      "class": "CCB + Direct Renin Inhibitor + Diuretic",
      "medications": ["Amturnide (Amlodipine/Aliskiren/HCTZ)"],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Quadruple mechanism for resistant HTN; monitor electrolytes closely."
      ]
    },
    {
      "id": "arb_ccb_combos",
      "name": "ARB/CCB Combinations",
      "class": "ARB + CCB",
      "medications": [
        "Azor (Olmesartan/Amlodipine)",
        "Exforge (Valsartan/Amlodipine)",
        "Twynsta (Telmisartan/Amlodipine)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe aortic stenosis"],
      "pearls": ["Dual mechanism for HTN; less cough than ACEi; monitor K+."]
    },
    {
      "id": "arb_ccb_diuretic_combos",
      "name": "ARB/CCB/Diuretic Combinations",
      "class": "ARB + CCB + Diuretic",
      "medications": [
        "Exforge HCT (Valsartan/Amlodipine/HCTZ)",
        "Tribenzor (Olmesartan/Amlodipine/HCTZ)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Pregnancy", "Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Triple mechanism for HTN; convenient combination; monitor electrolytes."
      ]
    },
    {
      "id": "vasodilator_diuretic_combos",
      "name": "Vasodilator/Diuretic Combinations",
      "class": "Vasodilator + Diuretic",
      "medications": ["Apresazide (Hydralazine/HCTZ)"],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Lupus exacerbation", "Severe renal impairment"],
      "pearls": [
        "For HTN in African Americans; monitor for drug-induced lupus."
      ]
    },
    {
      "id": "potassium_sparing_diuretic_combos",
      "name": "Potassium-Sparing Diuretic Combinations",
      "class": "Potassium-Sparing Diuretic + Thiazide",
      "medications": [
        "Dyazide (Triamterene/HCTZ)",
        "Maxzide (Triamterene/HCTZ)",
        "Moduretic (Amiloride/HCTZ)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to BP goal" },
      "avoid": ["Hyperkalemia", "Severe renal impairment"],
      "pearls": [
        "Spare potassium while providing diuresis; monitor K+ closely."
      ]
    },
    {
      "id": "anticoagulants",
      "name": "Anticoagulants",
      "class": "Anticoagulant",
      "medications": [
        "Apixaban (Eliquis)",
        "Dabigatran (Pradaxa)",
        "Enoxaparin (Lovenox)",
        "Edoxaban (Savaysa)",
        "Rivaroxaban (Xarelto)",
        "Warfarin (Coumadin, Jantoven)"
      ],
      "outpatient": { "maint": "Per agent dosing; monitor per protocol" },
      "avoid": ["Active bleeding", "Severe renal/hepatic impairment"],
      "pearls": [
        "DOACs preferred over warfarin for most; warfarin requires INR monitoring."
      ]
    },
    {
      "id": "antiplatelets",
      "name": "Antiplatelets",
      "class": "Antiplatelet",
      "medications": [
        "Aggrenox (Aspirin + Dipyridamole)",
        "Aspirin (Ecotrin, Empirin, Bayer, ASA)",
        "Clopidogrel (Plavix)",
        "Dipyridamole (Persantine)",
        "Prasugrel (Effient)",
        "Ticlopidine (Ticlid)",
        "Ticagrelor (Brilinta)"
      ],
      "outpatient": { "maint": "Per agent dosing; aspirin 81-325 mg daily" },
      "avoid": ["Active bleeding", "Severe hepatic impairment"],
      "pearls": [
        "Aspirin first-line for primary prevention; dual therapy for ACS/PCI."
      ]
    },
    {
      "id": "other_anticoagulants",
      "name": "Other Anticoagulants",
      "class": "Other Anticoagulant",
      "medications": [
        "Vorapaxar (Zontivity)",
        "Cilostazol (Pletal)",
        "Pentoxifylline (Trental)"
      ],
      "outpatient": { "maint": "Per agent dosing" },
      "avoid": ["Active bleeding", "Severe hepatic impairment"],
      "pearls": [
        "Vorapaxar for secondary prevention; cilostazol for PAD; pentoxifylline for claudication."
      ]
    },
    {
      "id": "antiarrhythmics",
      "name": "Antiarrhythmics",
      "class": "Antiarrhythmic",
      "medications": [
        "Adenosine (Adenocard)",
        "Amiodarone (Cordarone, Pacerone)",
        "Digoxin (Lanoxin, Digitek)",
        "Dronedarone (Multaq)",
        "Flecainide (Tambocor)",
        "Mexiletine (Mexitil)",
        "Propafenone (Rythmol, Rythmol SR)",
        "Sotalol (Betapace, Betapace AF)",
        "Tikosyn (Dofetilide)"
      ],
      "outpatient": { "maint": "Per agent dosing; monitor ECG/QT" },
      "avoid": ["Long QT syndrome", "Severe renal/hepatic impairment"],
      "pearls": [
        "Class-specific indications; monitor for proarrhythmia; many drug interactions."
      ]
    },
    {
      "id": "nitrates",
      "name": "Nitrates",
      "class": "Nitrate",
      "medications": {
        "Isosorbide Dinitrate": [
          "Isordil (Immediate release)",
          "Dilatrate SR (Extended release)"
        ],
        "Isosorbide Mononitrate": [
          "ISMO/Monoket (Immediate release)",
          "Imdur (Sustained release)"
        ],
        "Nitroglycerin": [
          "Nitroglycerin Ointment (Nitro-BID)",
          "Nitroglycerin Spray (Nitrolingual, NitroMist)",
          "Nitroglycerin Sublingual (Nitrostat, NitroQuick)",
          "Nitroglycerin Transdermal (Minitran, Nitro-Dur)"
        ]
      },
      "outpatient": {
        "maint": "Per formulation; apply patch 12-14 hrs/day with 12 hr break"
      },
      "avoid": ["Severe hypotension", "Recent PDE-5 inhibitor use"],
      "pearls": [
        "For angina; tolerance develops with continuous exposure; headache common."
      ]
    },
    {
      "id": "antiangina_other",
      "name": "Other Anti-Angina Agents",
      "class": "Anti-Angina",
      "medications": ["Ranolazine (Ranexa)"],
      "outpatient": { "maint": "500-1000 mg BID" },
      "avoid": ["QT prolongation", "Severe hepatic impairment"],
      "pearls": [
        "For chronic angina; prolongs QT interval; use with other antianginals."
      ]
    },
    {
      "id": "bile_acid_sequestrants",
      "name": "Bile Acid Sequestrants",
      "class": "Bile Acid Sequestrant",
      "medications": [
        "Cholestyramine (Questran, Questran Light)",
        "Colesevelam (Welchol)",
        "Colestipol (Colestid)"
      ],
      "outpatient": { "maint": "Per agent dosing; take with meals" },
      "avoid": ["Complete biliary obstruction", "Severe constipation"],
      "pearls": [
        "Lower LDL; may increase triglycerides; take with other lipid-lowering agents."
      ]
    },
    {
      "id": "epa_omega3",
      "name": "EPA/Omega-3 Fatty Acids",
      "class": "Omega-3",
      "medications": [
        "Vascepa (Icosapent ethyl)",
        "Lovaza (Omega-3 Fatty Acid)"
      ],
      "outpatient": { "maint": "Per agent dosing" },
      "avoid": ["Fish allergy", "Active bleeding"],
      "pearls": [
        "Lower triglycerides; Vascepa reduces CV events in high-risk patients."
      ]
    },
    {
      "id": "statins",
      "name": "Statins (HMG-CoA Reductase Inhibitors)",
      "class": "Statin",
      "medications": [
        "Atorvastatin (Lipitor)",
        "Fluvastatin (Lescol, Lescol XL)",
        "Lovastatin (Mevacor, Altoprev)",
        "Pitavastatin (Livalo)",
        "Pravastatin (Pravachol)",
        "Rosuvastatin (Crestor)",
        "Simvastatin (Zocor)"
      ],
      "outpatient": { "maint": "Start low dose, titrate to LDL goal" },
      "avoid": ["Active liver disease", "Pregnancy"],
      "pearls": [
        "First-line for dyslipidemia; monitor LFTs; muscle toxicity rare but serious."
      ]
    },
    {
      "id": "pcsk9_inhibitors",
      "name": "PCSK9 Inhibitors",
      "class": "PCSK9 Inhibitor",
      "medications": ["Praluent (Alirocumab)", "Repatha (Evolocumab)"],
      "outpatient": { "maint": "Per agent dosing; subcutaneous injection" },
      "avoid": ["Severe renal impairment", "Pregnancy"],
      "pearls": [
        "For severe hypercholesterolemia; very effective LDL reduction; expensive."
      ]
    },
    {
      "id": "fibrates",
      "name": "Fibrates",
      "class": "Fibrate",
      "medications": [
        "Fenofibrate (Tricor, Triglide, Antara, Lipofen)",
        "Fenofibric Acid (Trilipix, Fibricor)",
        "Gemfibrozil (Lopid)"
      ],
      "outpatient": { "maint": "Per agent dosing; take with food" },
      "avoid": ["Severe renal/hepatic impairment", "Gallbladder disease"],
      "pearls": ["Lower triglycerides; may increase LDL; monitor LFTs and CK."]
    },
    {
      "id": "niacin",
      "name": "Niacin",
      "class": "Niacin",
      "medications": ["Niacin (Vitamin B3, Niaspan, SloNiacin)"],
      "outpatient": { "maint": "500-2000 mg daily; titrate slowly" },
      "avoid": ["Active liver disease", "Gout", "Peptic ulcer disease"],
      "pearls": ["Lowers LDL and triglycerides; flushing common; monitor LFTs."]
    },
    {
      "id": "acl_inhibitors",
      "name": "ACL Inhibitors",
      "class": "ACL Inhibitor",
      "medications": [
        "Nexletol (Bempedoic acid)",
        "Nexlizet (Bempedoic acid/Ezetimibe)"
      ],
      "outpatient": { "maint": "Per agent dosing" },
      "avoid": ["Severe renal impairment", "Pregnancy"],
      "pearls": [
        "For LDL lowering; oral alternative to injectable PCSK9 inhibitors."
      ]
    },
    {
      "id": "lipid_combinations",
      "name": "Lipid-Lowering Combinations",
      "class": "Lipid Combination",
      "medications": ["Advicor (Lovastatin/Niacin)"],
      "outpatient": { "maint": "Per combination dosing" },
      "avoid": ["Severe hepatic impairment", "Gout"],
      "pearls": [
        "Convenient combinations; monitor LFTs and side effects of components."
      ]
    }
  ]
}
